Tiziana Life Sciences (TLSA) Invested Capital (2018 - 2021)

Tiziana Life Sciences (TLSA) has reported Invested Capital for 4 consecutive years, with $1.4 million the latest figure, recorded in Q4 2021.

• Quarterly Invested Capital fell 31.27% year-over-year to $1.4 million in Q4 2021, while the trailing twelve-month figure through Jun 2023 was $1.4 million (down 72.47% YoY) and the FY2021 annual result came in at $1.4 million, down 29.33% from the prior year.
• Invested Capital retreated to $1.4 million in Q4 2021 per TLSA's latest filing, from $1.6 million in the prior quarter.
• Over the last five years, Invested Capital for TLSA reached as high as $2.0 million in Q4 2020 and fell as low as $401067.7 in Q2 2020.
• A 4-year average of $981392.8 and a median of $579861.9 in 2019 frame the typical range for Invested Capital.
• The largest YoY upside for Invested Capital was 297.99% in 2021 against a maximum downside of 31.27% in 2021.
• Year by year, Invested Capital stood at $452942.1 in 2018, then gained by 28.02% to $579861.9 in 2019, then soared by 239.98% to $2.0 million in 2020, then tumbled by 31.27% to $1.4 million in 2021.
• According to Business Quant data, Invested Capital over the past three periods registered $1.4 million, $1.6 million, and $2.0 million for Q4 2021, Q2 2021, and Q4 2020 respectively.